Contracts Finder
Provision of Assay Kits for SCID & SMA In-Service Evaluations - EONIS-Q Revvity
NHS England
Awarded
supplies
SME-friendly
VCSE-friendly
This tender has closed
The submission deadline for this contract has passed. There may be more active supplies tenders from NHS England, and hundreds more across the UK public sector.
Key details
Contracting authority
NHS England
nhs
Region
Leeds
Sector
Contract value
£4,074,117ex VAT
Submissions closed
12 March 2026
Published
12 March 2026
Procurement
Contract period
1 April 2026 - 31 March 2029
3 years
Procedure type
Call-off from a framework agreement
CPV classifications
- 33100000 Medical equipments
What happened
NHS England awarded this contract to Revvity (UK) Limited worth £4,074,117 on 25 Mar 2026. The contract runs until 31 Mar 2029.
Description
EONIS-Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot in-service evaluation (ISE) for Severe Combined Immuno-Deficiency (SCID) in 4 Screening laboratories, with the addition of the ISE for Spinal Muscular Atrophy (SMA).
Awarded supplier
Supplier
Revvity (UK) Limited
Award value
£4,074,117
Award date
25 March 2026
Contact
Identifiers
Buyer reference
CF-3430100D0O000000rwimUAA
Notice ID
d1d6ec3d-8b57-42c2-bcc9-988c98df5b88-888234
OCID
ocds-b5fd17-63bc49a4-6875-44ee-bcf1-d9ea348f4445
Explore related tenders
Other tenders from NHS England
View all →Tech support for the dev. of the PCF requirements of the NHS Supplier Roadmap£96,000
Secondary Care Medicines Data Pre-Market Engagement£6,750,000
Targeted Prostate Cancer Screening Programme - MRI Reporting Service
Quality Assurance & Improvement of Structured Learning Placement (SLP) Modules£98,000
Targeted Prostate Cancer Screening Programme – PSA Laboratory Processing Service
External ID: cf-ocds-b5fd17-63bc49a4-6875-44ee-bcf1-d9ea348f4445 • Added 29 April 2026